BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
SOGP upcoming catalysts
Sound Pharmaceuticals, Incorporated: 2 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (1 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 3 readout(s) and 0 FDA event(s). Subscribe to SOGP (.ics).
Drugs: Ebselen, SPI-1005
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|
| No upcoming PDUFA date or AdCom found. |
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|
| 2026-12 est. | P2 | Sound Pharmaceuticals, Incorporated SOGP | NCT06340633 SPI-1005 in Adults Receiving Cochlear Implant | Hearing Loss; Cochlear Trauma | recruiting | 40 |
| 2026-12 est. | P3 | Sound Pharmaceuticals, Incorporated SOGP | NCT06859788 SPI-1005 for the Treatment of Meniere's Disease (Open Label) | Meniere's Disease; Ménière's Disease | active not recruiting | 200 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|
| No FDA decision events in this window. |
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|
| 2026-06 est. | P2 | Sound Pharmaceuticals, Incorporated SOGP | NCT02779192 A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss | Noise Induced Hearing Loss | withdrawn | |
| 2026-06 est. | P2 | Sound Pharmaceuticals, Incorporated SOGP | NCT01451853 SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss | Lung Cancer; Head and Neck Cancer; Hearing Loss; Ototoxicity; Tinnitus; Neuropathy | withdrawn | |
| 2026-01-31 est. | P3 | Sound Wave Innovation CO., LTD. SOGP | NCT05983575 A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease | Alzheimer Disease, Early Onset | active not recruiting | 220 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.